サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566774

胃内バルーン市場：タイプ別、充填材料別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年

Intragastric Balloons Market By Type (Single, Dual, Triple), By Filling Material (Gas Filled, Saline Filled) By End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 216 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
胃内バルーン市場：タイプ別、充填材料別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 216 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の胃内バルーン市場は、2023年に3,220万米ドルと評価され、2024～2033年にかけてCAGR 13.6%で成長し、2033年には1億1,530万米ドルに達すると予測されています。

胃内バルーンは手術を必要としない医療機器であり、胃内のスペースを確保することで満腹感をもたらし、食事量を減らすことで体重減少を補助する目的で開発されました。このバルーンは、内視鏡手術によって胃に入れられ、生理食塩水またはガスで満たされて胃の一部を占め、食事摂取能力を低下させる。この方法は、低カロリー食を守り、より健康的な食習慣を身につけ、体重減少をサポートします。これらのバルーンは、胃バイパス術やスリーブ状胃切除術などの外科手術を受ける資格がない、あるいは避けたいと考えている肥満症患者にとって特に有利です。

胃内バルーン市場の成長を牽引しているのは、座りがちなライフスタイル、不健康な食生活、遺伝的素因など、さまざまな要因に関連する肥満率の上昇です。こうした要因が世界的に広まるにつれ、肥満の発生率は上昇の一途をたどっています。その結果、これらの健康リスクを軽減し、全身の健康を改善するために、効果的な減量ソリューションを求める個人が増加しています。このような肥満管理ソリューションに対する需要の高まりは、減量に低侵襲的なアプローチを提供する胃内バルーンなどの介入市場を牽引しています。例えば、低侵襲治療を希望する患者の57.0%は、低侵襲治療を勧められ、治療後のデメリットの認知が少ないと報告されたことから、医療専門家の影響下で決定を下しています。

しかし、償還政策の欠如が胃内バルーン導入の妨げとなっています。多くの医療システムでは、胃内バルーン治療に対する保険適用は不十分であるか、存在しないことが予想され、その結果、患者の自己負担額は高額になります。この経済的障壁は、特に経済的に余裕のない患者や保険適用が不十分な患者が治療を受けることを躊躇させる。一方、新製品の採用は、市場の成長に有利な機会を記載しています。例えば、2022年9月、米国の医療機器メーカーであるAllurion Technologiesは、減量ソリューションである嚥下可能な胃バルーンをインドで発売しました。同製品は、16週間以内に平均10～15％体重を減少させるとしています。

セグメント概要

胃内バルーン業界は、タイプ、充填材料、エンドユーザー、地域に区分されます。タイプ別では、シングル、デュアル、トリプルに分類されます。充填材によって、ガス充填型と生理食塩水充填型に二分されます。エンドユーザー別では、病院、外来手術センター（ASC）、その他に分類されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。

主要調査結果

タイプ別では、2023年の胃内バルーン市場で最大の収益を上げたのは単一セグメントでした。

充填材料別では、生理食塩水充填セグメントが2023年の市場で最も高いシェアを占めました。

エンドユーザー別では、病院セグメントが2023年に最大の市場シェアを占めました。

地域別では、北米が2023年の胃内バルーン市場を独占しました。

競合シナリオ

本レポートはカスタマイズが可能です。

  • 規制ガイドライン
  • 顧客の関心に応じた追加企業プロファイル
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 過去の市場データ

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 胃内バルーン市場：タイプ別

  • 市場概要
  • シングル
  • デュアル
  • トリプル

第5章 胃内バルーン市場：充填材料別

  • 市場概要
  • ガス充填
  • 生理食塩水充填

第6章 胃内バルーン市場：エンドユーザー別

  • 市場概要
  • 病院
  • 外来手術センター
  • その他

第7章 胃内バルーン市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の胃内バルーン市場
    • カナダの胃内バルーン市場
    • メキシコの胃内バルーン市場
  • 欧州
    • 主要市場動向と機会
    • フランスの胃内バルーン市場
    • ドイツの胃内バルーン市場
    • イタリアの胃内バルーン市場
    • スペインの胃内バルーン市場
    • 英国の胃内バルーン市場
    • その他の欧州胃内バルーン市場
  • アジア太平洋
    • 主要市場動向と機会
    • 中国の胃内バルーン市場
    • 日本の胃内バルーン市場
    • インドの胃内バルーン市場
    • 韓国の胃内バルーン市場
    • オーストラリアの胃内バルーン市場
    • その他のアジア太平洋の胃内バルーン市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの胃内バルーン市場
    • 南アフリカ共和国の胃内バルーン市場
    • サウジアラビアの胃内バルーン市場
    • その他のラテンアメリカ・中東・アフリカの胃内バルーン市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Obalon Therapeutics
  • Apollo Endosurgery Inc.
  • Allurion Technologies Inc.
  • Spatz Medical
  • ReShape Lifesciences
  • Lexel Medical
  • Endalis
  • MEDSIL
  • Silimed Industria De Implantes Ltda.
目次
Product Code: A03775

The global intragastric balloons market was valued at $32.2 million in 2023, and is projected to reach $115.3 million by 2033, growing at a CAGR of 13.6% from 2024 to 2033.

Intragastric balloons are medical devices that do not require surgery and are created to aid in weight loss by taking up space in the stomach, leading to a sensation of fullness and decreased food consumption. These balloons are placed in the stomach through an endoscopic procedure and are filled with saline or gas to occupy a part of the stomach, reducing its capacity for food intake. This method helps people stick to low-calorie diets and develop healthier eating habits, which in turn supports weight loss. These balloons are especially advantageous for individuals dealing with obesity who may not be eligible for or prefer to avoid surgical procedures such as gastric bypass or sleeve gastrectomy.

The growth of the intragastric balloons market is driven by rise in the obesity rates related to various factors such as sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. As these factors become more prevalent globally, the incidence of obesity continues to rise. Consequently, individuals are increasingly seeking effective weight loss solutions to mitigate these health risks and improve their overall well-being. This growing demand for obesity management solutions drives the market for interventions such as intragastric balloons, which offer a minimally invasive approach to weight loss. For instance, 57.0% of the patients who preferred minimally invasive treatment made their decision under the influence of the healthcare professionals as they recommended minimally invasive treatment and reported less perceived disadvantages following their treatment.

However, lack of reimbursement policies hinders the adoption of intragastric balloons. In many healthcare systems, the coverage for intragastric balloon procedures is expected to be insufficient or non-existent, resulting in high out-of-pocket costs for patients. This financial barrier deters individuals from seeking treatment, particularly those with limited financial resources or inadequate insurance coverage. On the other hand, introduction of new products offers lucrative opportunities for the growth of the market. For instance, in September 2022, Allurion Technologies, the U.S.-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India. The product claims to reduce weight by 10-15% on average within 16 weeks.

Segmentation Overview

The intragastric balloons industry is segmented into type, filling material, end user, and region. By type, the market is classified into single, dual, and triple. Depending on the filling material, it is bifurcated into gas filled and saline filled. According to end user, the market is categorized into hospitals, ambulatory surgical centers (ASC), and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the single segment generated the largest revenue in the intragastric balloons market in 2023.

Depending on the filling material, the saline filled segment held the highest share in the market in 2023.

According to end users, the hospitals segment accounted for the largest market share in 2023.

Region wise, North America dominated the intragastric balloons market in 2023.

Competitive Scenario

The major players operating in the intragastric balloons market include Obalon Therapeutics, Apollo Endosurgery Inc., Allurion Technologies Inc., Spatz Medical, ReShape Lifesciences, Lexel Medical, Endalis, MEDSIL, and Silimed. Other players in the intragastric balloons market include Districlass Medical, and Helioscopie. These players have adopted several strategies, including mergers & acquisitions, partnerships, collaborations, and product innovation & diversification to maintain their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type

  • Single
  • Dual
  • Triple

By Filling Material

  • Gas Filled
  • Saline Filled

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Obalon Therapeutics
    • Apollo Endosurgery Inc.
    • Allurion Technologies Inc.
    • Spatz Medical
    • ReShape Lifesciences
    • Lexel Medical
    • Endalis
    • MEDSIL
    • Silimed Industria de Implantes Ltda.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: INTRAGASTRIC BALLOONS MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Single
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Dual
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Triple
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: INTRAGASTRIC BALLOONS MARKET, BY FILLING MATERIAL

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Filling Material
  • 5.2. Gas Filled
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Saline Filled
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: INTRAGASTRIC BALLOONS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: INTRAGASTRIC BALLOONS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Filling Material
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Intragastric Balloons Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Filling Material
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Intragastric Balloons Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Filling Material
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Intragastric Balloons Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Filling Material
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Filling Material
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Intragastric Balloons Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Filling Material
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Intragastric Balloons Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Filling Material
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Intragastric Balloons Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Filling Material
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Intragastric Balloons Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Filling Material
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Intragastric Balloons Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Filling Material
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Intragastric Balloons Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Filling Material
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Filling Material
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Intragastric Balloons Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Filling Material
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Intragastric Balloons Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Filling Material
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Intragastric Balloons Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Filling Material
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Intragastric Balloons Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Filling Material
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Intragastric Balloons Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Filling Material
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Intragastric Balloons Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Filling Material
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Filling Material
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Intragastric Balloons Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Filling Material
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Intragastric Balloons Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Filling Material
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Intragastric Balloons Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Filling Material
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Intragastric Balloons Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Filling Material
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Obalon Therapeutics
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Apollo Endosurgery Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Allurion Technologies Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Spatz Medical
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. ReShape Lifesciences
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Lexel Medical
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Endalis
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. MEDSIL
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Silimed Industria De Implantes Ltda.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments